Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.

Inclusion Criteria:

Site Eligibility (as per SC self-report)

& Must be designated as an American College of Radiology (ACR) designated lung cancer screening site

• Reports at least one year of lung cancer screening experience
• Reports conducting at least 20 new initial screenings per month Site Coordinator (SC) Eligibility (as per SC self-report)
• Employed as a full-time Site Coordinator at participating lung cancer screening site Patient Eligibility (as per self-report)
• Between the ages of 50-80 years old
• Seeking baseline or annual follow-up LDCT lung cancer screening
• Have at least a 20 pack-year history of smoking
• Currently a smoker, defined as self-reported cigarette smoking (some days, every day) within the past 30 days.
• Must be reachable by telephone
• Must be English or Spanish speaking due to the study materials being available in only these languages and limited available resources for translation.

Exclusion Criteria:

Patient (as per self-report)

• NRT is medically contraindicated (e.g., recent heart attack within the last 2 weeks or, unstable/worsening angina).
• Smokers who are receiving other tobacco treatment services or have used cessation medications (NRT, bupropion, varenicline) within the past month.